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Chemical modifications on messenger RNA have been recently revealed by 
biological researchers to function as an essential layer of gene expression 
regulation. Molecular biologists from different laboratories have conducted more 
than 200 sets of high throughput sequencing experiments trying to capture the 
types and locations of messenger RNA modifications across multiple cell types 
and species. However, until this date, the field still lacks a bioinformatics pipeline 
to quantify and analyze the epitranscriptomic HTS data generated from different 
laboratories consistently. The thesis aims to provide an overview of questions 
and challenges arisen in the field of mRNA modification computational analysis. 
Subsequently, we will present a set of practical computational strategies for data 
explorations, genomic data mining, modification level quantifications, and 
technical artifact corrections from a data science perspective. The first chapter of 
the thesis provides an in-depth data exploration and visualization of m5C mRNA 
modification from bisulfite sequencing data. In the second chapter, 
we document the database construction and data consistency exploration for the 
transcriptomic targets of the mRNA modification related protein regulators. 
Besides, the second chapter presents a methodological framework for the 
computational representation of the domain knowledge related to the 
transcriptomic topology of epitranscriptomic modification. The final section of the 
thesis discusses the dominant technical biases existed in MeRIP-Seq, the most 
widely applied type of HTS data in epitranscriptomics, and it follows with a 





Topological characterization of human and mouse m5C 
epitranscriptome revealed by bisulfite sequencing 
 
1.1 Outline 
Background: Compared with the well-studied 5-methylcytosine (m5C) in DNA, the role 
and topology of epitranscriptome m5C remain insufficiently characterized.  
Results: Through analyzing transcriptome-wide m5C distribution in human and mouse, 
we show that the m5C modification is significantly enriched at 5’ untranslated regions 
(5’UTRs) of mRNA in human and mouse. With a comparative analysis of the mRNA and 
DNA methylome, we demonstrate that, like DNA methylation, transcriptome m5C 
methylation exhibits a strong clustering effect. Surprisingly, an inverse correlation 
between mRNA and DNA m5C methylation is observed at CpG sites. Further analysis 
reveals that RNA m5C methylation level is positively correlated with both RNA expression 
and RNA half-life. We also observed that the methylation level of mitochondrial RNAs is 
significantly higher than RNAs transcribed from the nuclear genome.  
Conclusions: This study provides an in-depth topological characterization of 
transcriptome-wide m5C modification by associating RNA m5C methylation patterns with 
transcriptional expression, DNA methylations, RNA stabilities, and mitochondrial 
genome. 
 
Keywords: RNA 5-methylcytosine (m5C), mRNA methylation, RNA bisulfite sequencing, 









BS-Seq: bisulfite sequencing 
MDA-MB-468: MDA468 
MEF: mouse embryo fibroblast 
MEF-Dnmt2-: mouse embryo fibroblast with Dnmt2 knock down 
WGBS: whole genome bisulfite sequencing 
RRBS: reduced representation bisulfite sequencing 
mRatio: methylation ratio 
OR: odds ratio 
DMS: differential methylation site 
lncRNA: long noncoding RNA 
sncRNA: small noncoding RNA 
 
1.2 Introduction 
DNA methylation is a well-established and extensively studied epigenetic phenomenon 
[1-4]. In contrast, mRNA methylation is still relatively an uncharted territory [5]. 
Although the presence of the chemical modifications to tRNA has been established in 
the 1970s [6-8], little is known about the epigenetic modifications to mRNA and other 
non-coding RNAs.  Even less was known about their abundance, role, and mode of 
regulation until recently when several studies showed that N6-methyladenosine (m6A) is 
the most abundant messenger RNA (mRNA) modification in eukaryotes [9], and 
suggested to regulate a number of biological processes including translation efficiency 
[10], circadian clock [11], microRNA processing [12], RNA-protein interaction [13], RNA 
stability [14], heat shock response [15] and differentiation [16].  
 
Compared to m6A, even little is known about the abundance and role of transcriptome 
5-methylcytosine (m5C) modification. Existing studies of m5C in cellular RNA have been 
largely confined to rRNA and tRNA [17]. For example, RNA m5C modification in plant 
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rRNA and tRNA is reported to be conserved [18], and is shown to affect stability of 
synthetic RNA [19, 20]. In mammalian system, cytosine-5 methylation in tRNA has been 
shown to regulate Mg2+ binding, anticodon stem loop conformation and secondary 
structure stabilization [21, 22]. In addition, m5C in tRNAs is reported to regulate protein 
translation in stress response, tissue differentiation, and neuro-development disorders 
[23-29]. In rRNA, m5C is shown to regulate translation process [30]. A recent study also 
showed that, hm5C, the intermediate of RNA m5C demethylation, is enriched in poly-A 
tailed RNA and the coding sequences of the mRNA transcript, and it is associated with 
brain development and the active transcription of mRNA [11]. 
 
Recent advancement of RNA bisulfite sequencing (BS-Seq) technique [31-34] has 
enabled the transcriptome-wide m5C profiling at single base resolution and confirmed its 
widespread existence in the human transcriptome [34, 35].  Intriguing differences with 
respect to the degree of transcriptome m5C methylation, functional classification and 
position bias were reported with this technique [36], and it was recently shown that 
transcriptome m5C promotes mRNA export through methyltransferase NSUN2 and 
reader ALYREF [37]. 
 
It is observed that m5C modification may accounts for 20% of the total internal 
methylations on ploy(A) RNA in BHK21 cell line [38, 39]. However, it is not clear that 
whether the transcriptome m5C modification is differentially enriched in different cell 
types, and the topological relationship between RNA methylation and DNA methylation 
under the same cell lines has not been investigated. 
 
In this study, using BS-Seq approach, we identified transcriptome-wide mRNA m5C 
methylome in mouse and human cells. Our results revealed that transcriptome m5C is 
enriched and conserved at the 5’UTRs of target transcripts in both human and mouse 
cells. Interestingly, under all the examined cell lines, we observed a negative correlation 
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of the methylation patterns between RNA m5C methylation and DNA m5C under CpG 
context, and the RNA m5C methylations are enriched on mitochondria transcriptome. 
 
1.3 Material and Methods 
Sample preparation and RNA bisulfite sequencing  
MCF10A normal mammary epithelial cells and MDA-MB-468 breast cancer cells were 
obtained from ATCC. MCF10A cells were cultured and maintained in DMEM/F12 (Life 
Technologies, USA) supplemented with 5% Horse serum, EGF (20 ng/ml), Hydrocortisone 
(0.5 µg/ml), Insulin (10 µg/ml) and Anti-Anti (Life Technologies, USA). Likewise, MDA-
MB-468 cells were cultured in RPMI (Life Technologies, USA) supplemented with 10% 
FBS and Anti-Anti (Life Technologies, USA). For BS-Seq total RNA was isolated from 
MCF10A and MDA-MB-468 cells and was enriched for polyA+ RNA using poly-A selection 
kits. The purified RNA is subjected to sodium bisulfite treatment at 60 degrees for 8 
hours. The bisulfite-treated RNA was then reverse transcribed and subjected to deep-
sequencing using Illumina RNA-Seq protocol. The data has been deposited under Gene 
Expression Ominous (GEO) with Accession Number GSE84230. To replenish the 
transcriptome BS-Seq data of aforementioned human samples (MCF10A and MDA-MB-
468), additional datasets are obtained from public resources, including DNA BS-Seq data 
from MCF10A (GEO GSM659628) [40], transcriptome  m5C methylation data from mouse 
embryo stem cell (ESC) and mouse whole brain profiled by RNA BS-Seq (GEO GSE83432) 
[41], and mouse ESC DNA methylation data (GSM1873374) [7, 42].  
 
Quality control and alignment of BS-Seq data 
The FASTQ files from BS-Seq samples are trimmed with Trim Galore [43], it removes low 
quality 3’ ends with phred score threshold of 20, and it can remove potential adaptor 
contamination. Then, the reads are aligned to the reference genomes of mouse and 
human (mm10 and hg19) with MeRanGs in MeRanTK [44]. The methylation is called 
using MeRanCall, regions of the 5’ends and 3’ends of the reads are ignored based on the 
threshold cut-off suggested by the M-bias plot generated by meRanGs. The minimum 
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reads coverage for the methylation report was set at 10, and the minimum read base 
quality (phred score) for methylation call is filtered at 30. The maximum reads 
duplication level is set at 10 to prevent the PCR artefacts; the minimum non-conversion 
rate to report is set at 0 to include the non-methylated sites as background control for 
further analysis.  
 
For DNA bisulfite samples, the trimmed reads are aligned using Bismark under alignment 
setting --score_min L,0,-0.6. The SAM files are filtered by Samtools using -F 1540 and -q 
30 to remove reads that are duplicated and whose Quality scores are lower than 30. The 
methylation status of genome-wide cytosine sites is reported from the filtered SAM files 
with Bismark methylation extractor with argument --cytosine report. Also, the 
conversion rate biased ends are also ignored during methylation call based on the M-
bias plots. The minimum read coverage was filtered at 10 as well.  
 
Filtering false positive m5C sites due to RNA secondary structure 
 
Figure 1. Association between reported methylated sites and double stranded RNA 
structures before filtering. The reported m5C sites by MeRanTK approach are clearly 
enriched with double stranded RNA structure before the filtering, and the pattern is 
consistent in all the 4 samples. The odds ratio (OR) was calculated from Fisher’s exact 
test and the error bar shows the 95% confidence interval of OR estimation.  
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It is known that, secondary structures on RNAs prohibit bisulfite conversion and thus can 
result in false positive detection of transcriptome m5C sites. As shown in Figure 1, the 
detected m5C sites from meRanTK are enriched with double stranded regions of RNA, 
which are likely to be false positive errors due to secondary structure. For this reason, an 
R package rBS2ndStructure was created to facilitate the elimination of the false positive 
methylation calls due to RNA secondary structures. Specifically, RNA secondary structure 
is predicted with RNAfold from the Vienna RNA package [45] as it was performed by 
Amort et.al [41]. The transcriptome wide full length transcripts are extracted from UCSC 
gene annotation for both mm10 and hg19. Then, the double stranded structures are 
predicted with the MEA method under alpha = 0.1. The folding temperature is set at 70 
degree, and the maximum pairing distance is set at 150bp. For the mitochondria 
chromosome and the transcripts longer than 8000bp, the structures are predicted using 
sliding windows of 2000bp and step size of 1000pb.  For both the RNA and the DNA 
methylation reports, the methylation sites overlapped with the predicted regions of 
secondary structures are filtered. Due to the lack of computational resources to predict 
structures on large intronic sequences, the cytosine sites that do not locate on the exons 
of known transcripts or the mitochondria chromosome are filtered. The resulting 
methylation reports are then analysed under R environment using primarily 
GenomicFeatures [46], Guitar [47] and ggplot2 [48] packages.  
 
The rBS2ndStructure package is publically available at Github (https://github.com/ZW-
xjtlu/rBS2ndStructure) with precomputed RNA secondary structures of genome 
assembly mm10 and hg19 for convenient processing of RNA BS-Seq result.  
 
Quantitative analysis of methylation status   
The methylation ratio (mRatio) of a specific Cytosine site is calculated by: 
   (1) 
# of unconverted Csmethylation ratio 
# of unconverted Cs + # of converted Cs
=
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where “# of unconverted Cs” and “# of converted Cs” indicates the count of methylated 
(un-converted) Cs and unmodified Cs (converted Cs) at a specific Cytosine site, 
respectively.  The methylation rate is conceptually similar to the well adapted concept of 
“beta value” in DNA methylation analysis [49], which indicates the percentage of 
methylated Cs among all Cs. Also, it is not difficult to show that 
   (2) 
where the conversion rate has been previously defined in [35] and a smaller value 
suggests higher percentage of RNA m5C methylation.  
 
To differentiate a set of statistically significantly methylated Cytosine sites against 
potential technical randomness due to incomplete bisulfite conversion, the p values for 
the methylation state of both the DNA and RNA methylation are calculated by fisher 
exact test which against the background conversion odds after the filtering of the sites 
mapped to introns and secondary structures. The adjusted pvalues (FDR) are then 
adjusted by Benjamin & Hochberg method. The positive methylation states were 
decided when FDR < .05.   
 
For the mouse samples containing 3 biological replicates, the methylated sites are 
judged as FDR <.05 among all 3 replicates. For other insignificant methylated sites to be 
kept in the analysis, the sites should be reproduced 3 times with coverage > 10. The 
converted reads and non-converted reads are added on each site when combining the 
biological replicates. 
 
The background bisulfite non-conversion rate is 2.75%, 2.74%, 1.18% and 0.81% for 
MCF10A, MDA468, mouse ESC and mouse brain- samples, respectively (taking average 
for samples with more than one biological replicates). The difference among non-
# of unconverted Cmethylation ratio 
# of unconverted C + # of converted C
# of converted C1






conversion rates might be due to the biological difference of cell-lines, batch variation 
and different BS-Seq protocols.  
 
Differential methylation analysis 
The odds ratio (OR) or methylation fold change from differential analysis is defined as:  
 .  (3) 
Odds ratio (or methylation fold change) indicates whether the methylation is enriched 
under one condition compared with another condition. A value greater than 1 suggests 
increased methylation level, where as a value less than 1 suggests decreased 
methylation level. The statistical significance of the odds ratio is evaluated by QNB 
method, which tests the homogeneity of association between methylated and 
unmodified molecules under two experimental conditions with the within-group 
variability assessed through 4 cross-linked negative binomial distributions [50]. 
 
Similar to the odds ratio from differential methylation analysis, the enrichment odds 
ratio of m5C sites within a specific region can be defined as: 
   (4) 
A value greater than 1 suggests that methylation sites are enriched within the tested 
region. And the statistical significance of enrichment can be evaluated by Fisher’s exact 
test. Please note that, in this analysis, we used the total number cytosine sites reported 
from meRanTK rather than total number of all 4 types of nucleotides.  
 
Assessing the distribution of m5C sites on mRNA 
# of unconverted Cs under cond_1
odds ratio # of converted Cs under cond_1   = 
from differential methylation # of unconverted Cs under cond_2









# of m C sites within a region
# of C sites within a region
enrichment odds ratio  = 
total # of m C sites








The distribution pattern of m5C sites on mRNA is assessed with the Guitar 
R/Bioconductor [47]. Compared with other software tools and methods, Guitar package 
provides an improved resolution by relying on only the mRNA transcripts that have 
sufficient long (more than 100bp) 5’UTR, CDS and 3’UTR simultaneously. For instance, 
transcripts without annotated 5’UTRs will be excluded from the analysis. Additionally, 
Guitar doesn’t rely on only the primary transcript (often defined as the longest transcript 
among all isoforms in practice) when solving ambiguous association between a m5C site 
and the isoform transcripts of a gene; instead, all ambiguous associations are considered 
with the weight of association evenly divided. For example, if a single m5C site locates on 
3’UTR of a transcript and CDS of another isoform transcript of that gene, it is counted as 
half of the m5C site is located on 3’UTR and the other half located on 5’UTR. In this way, 
the isoform information is largely retained. To our knowledge, Guitar package should 
provide the most accurate assessment of transcriptomic distribution pattern. 
 
Differential expression analysis 
Differential expression analysis was performed with DESeq2 package [51] and the 
aligned RNA BS-Seq data. 
 
Cell culture and viral infection 
Jurkat T Lymphocytes were maintained in RPMI 1640 medium (Hyclone) supplemented 
with 5% (v/v) FBS (Gibco) and 100U/ml penicillin/streptomycin (Hyclone). For infection, 
Jurkat cells were infected with known amounts (3 X 108 genome copies per 2 X 105 
cells) of SRV for 18 hours at 37℃, followed by three times wash with PBS (Hyclone). 
Infected cells were incubated in completed culture medium for the indicated time. 
Successful infection was identified as the appearance of cytopathic effects in infected 
cells at 8 to 10 days postinfection.  
 
Reverse transcription and realtime PCR 
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SRV genome in culture medium was extracted by viral RNA extraction kit (TIANGEN) and 
reverse transcripted into cDNA by reverse transcriptase PCR kit (TaKaRa). Cellular 
genome was extracted by TIANamp Genomic DNA Kit (TaKaRa). Realtime PCR was 
performed in 7500 Fast Real-Time PCR System (Applied Biosystems) by using Premix Ex 
Taq (Probe qPCR) kit (TaKaRa). SRV genome positive control, primers and probe; as well 
as GAPDH primers and probe were kindly provided by VRL China Ltd [52]. 
 
Immunofluorescence assay 
Cells were seeded on poly-L-lysine (Sigma) coated slides, fixed with 4% 
paraformaldehyde for 15 minutes, followed by permeabilized with pre-cold pure 
methanol for 20min at -20℃ and blocked with 5% BSA for 1 hour. Cells were then 
stained with the serum from SRV infected monkey (1:25 diluted in blocking buffer) 
overnight and visualized with DyLightTM 488-Labeled anti-Human antibody (KPL). Cells 
were counterstained with Hoechst (Life Technologies) for 10 minutes and mounted on 




Overview of mRNA m5C methylome revealed by BS-Seq 
 
Figure 2. Distribution of RNA and DNA methylation ratio. The diagram shows the 
distribution of RNA and DNA methylation ratio under 4 different conditions. In general, 
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DNA methylation ratio is much higher than RNA. The distribution patterns of biological 
replicates are relatively close.  
 
After successful processing of the RNA BS-Seq datasets, a total of 3440 (0.40%), 1915 
(0.29%), 35246 (0.757%) and 25301 (0.50%) RNA cytosine sites were identified as m5C 
methylation (FDR < 0.05) sites in MCF10A, MDA-MB-468, mouse embryonic stem cell 
(ESC) and mouse whole brain, respectively. The overall transcriptome m5C methylation 
level was much lower than DNA m5C methylation level (Figure 2). Importantly, we found 
that m5C was widespread in different RNA families, where more than 50% of them were 
located on mRNA (Figure 3a). In MCF10A cells, 7131 protein coding genes had sites 
reported after the filtering, of which 225 (3.15%) mRNAs contained m5C sites. In MDA-
MB-468 cells, 6320 protein coding genes had reads aligned, of which 128 (2.06%) 
contained m5C sites. In ESC and brain- samples, the methylation status were available for 
11325 and 13108 protein coding genes, of which 3579 (31.6%) and 3065 (23.4%) 
contained m5C sites. The difference in number of m5C sites between different conditions 





Figure 3. Distribution of transcriptome m5C modification sites in human and mouse. 
(a) The pie chart shows transcriptome wide distribution of m5C sites in MCF10A, MDA-
MB-468, mouse embryonic stem cell (ESC) and whole brain. The majority of the 
identified m5C sites are located on mRNAs. (b) Graph showing status of m5C frequency 
in different regions of mRNA.  The result indicates that, detected Cytosine sites are 
consistently enriched at 5’UTR on mRNA compared with CDS and 3’UTR. 
 
mRNA m5C is enriched in 5’UTRs of human and mouse 
To study the spatial organization of m5C sites in the transcriptome, we first analysed the 
relative enrichment (see methods for more details) of m5C sites on different types of 
RNA and at different regions (shown in Figure 3b) by compensating for the Cytosine sites 
that do not carry m5C modification. Our results showed that m5C sites were consistently 
and significantly enriched at 5’UTRs in human and mouse with enrichment odds ratio of 
3.138, 4.802, 2.744 and 1.601. The similar topology was already reported by the 
previous studies [35, 36], and our observation further confirm their conclusions.  Also 
we did observe a slight enrichment of m5C sites in 3’UTR in mouse brain (enrichment 
odds ratio = 1.013 and 1.19E-02), which is also reported in the study of Almert.et al [36],  






Figure 4. Conservation of m5C in different mRNA regions. (b) Graph showing status 
of m5C frequency in different regions of the transcripts.  We divided all the detected 
Cytosine sites into 2 groups based on whether it is methylated. The result indicates that, 
Cytosine sites with significant methylation levels are consistently enriched at 5’UTRs 
and near start codon in all 4 samples. The m5C sites in mouse brain are peaked at 3’UTR 
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and CDS compared with other samples. However, the background sites in mouse brain 
samples are also peaked around 3’UTR and CDS. Therefore, the relative enrichment of 
the mouse brain sample is still at the 5’UTR, as it is shown in figure 3b. The differences 
in the distributions of background sites might be attributed to substantial differences in 
the transcript expression profiles between the mouse brain samples and other samples.   
(b) A correlated methylation pattern is observed on 5’UTRs between different cell 
lines/tissues in human and mouse. The conserved Cytosine residuals were retrived with 
liftOver utility (http://genome.ucsc.edu/cgi-bin/hgLiftOver). And the correlation analysis 
is performed with a Fisher’s exact test. It is important to note that, although we failed to 
observe correlated m5C methylation pattern on CDSs and 3’UTRs of mRNA across all 4 
pairings, it is possible that such pattern may emerge on strictly matched cell lines/tissues. 
 
To further substantiate these findings, we plotted the distribution of the methylated and 
un-methylated Cytosine sites locate on mRNAs with Guitar package [47].  In order to 
improve the resolution of this analysis and differentiate the distribution of m5C sites on 
usually short 5’UTRs, only the mRNAs with a 5’UTR longer than 100 bp are used. As 
shown in Figure 4a, the methylated Cytosine sites were consistently enriched at 5’UTRs 
across all 4 samples when compared to un-methylated groups. Interestingly, this trend is 
also supported by the Cytosine methylation sites reported by Squires et al. [35], and 
there is no significant enrichment of m5C sites observed in 3’UTR when all cytosine 




Figure 5. mRNA m5C sites are enriched at 5’UTRs in HeLa cells. The 10275 RNA 
methylation sites from Hela cell line are extracted from a previous study (1). Compared 
with the background (all the transcriptomic Cytosine sites), the reported mRNA m5C 
methylation sites are more enriched on 5’UTR. Prominent enrichment is not observed on 
3’UTR. This trend is consistent with the other 4 samples tested (See Figure 1 of the main 
text). Figure is plotted using default setting of Guitar package (2) with human hg19 
genome assembly and UCSC gene annotation.  
 
We further compared the methylation status of the conserved locus in human and 
mouse between different cell lines/tissues. After pairing the cytosine sites of human and 
mouse by LiftOver, the correlation of m5C sites between species is quantified using the 
odds ratio association of the significant modification sites against background sites 
between 2 samples under a given transcript region. The odds ratio value larger than 1 
indicates a positive association on m5C positive sites between species, since it suggests a 
tendency for evolutionary conservation. It is observed that, although the cell 
types/tissues we used are not strictly matched, a consistently positively correlated 
methylation pattern is observed on 5’UTR region (Figure 4b).  However, unlike 5’UTR, 
correlated pattern of m5C sites were not consistently observed in CDSs or 3’UTRs in our 
study, the observed heterogeneity of the m5C methylome in different transcript regions 
suggests that the m5C mapped to 5’UTR of the transcripts are more likely to be 
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functional important.  High degrees of associations are also observed in Brain vs 
MDA468 and ESC vs MCF10A under 3’UTR. This pattern suggests that some of the m5C 
sites on 3’UTR are evolutionary conserved, although the conserved sites may not be 
consistently expressed under all cell line conditions. 
 
m5C site exists under different nucleotide contexts 
 
Because RNA methyltransferase Dnmt2 shares strong sequence homology to all DNA 
DNMT methyltransferases [53], we reason that exploring the relationship between 
transcriptome and DNA m5C methylation profiles may unravel interesting interplay 
between the two kinds of reversible chemical modifications. In mammalian cells, DNA 
methylation occurs mainly at CG dinucleotides (including ACG, CCG, TCG and GCG, See 
Figure 6b). To study whether, like DNA methylation, transcriptome m5C methylation also 
occurs at the similar position, we analysed methylated cytosine in the transcriptome. For 
this purpose, we examined the all possible C-centred trinucleotide combinations. Unlike 
DNA, transcriptome m5C occurs at all C-centred trinucleotides (Figure 6a), and was 
observed to be specifically enriched at GCA, ACG, CCG, GCG, CCC, and GCC. These results 
were found to be consistent within the same species (Pearson correlation = 0.96 and 
0.92, Figure 6c) and between different species (Pearson Correlation = 0.72, 0.75, 0.45 





Figure 6. Comparative distributions of mRNA and DNA m5C methylation. (a) Bar 
graph shows the proportion of mRNA m5C sites under different combination of C-
centered trinucleotides in mouse and human cells. The dotted line shows the average 
percentage of methylation under all trinucleotide contexts within the entire transcriptome. 
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We observed that RNA m5C occurs under all trinucleotide contexts and showed slightly 
enriched in sequences containing CCG, GCG, GCC, GCU and GCA. (b) Bar graph 
showing proportion of DNA m5C sites in mouse and human cells.  DNA cytosine sites 
were enriched exclusively in sequences containing CG dinucleotides (ACG, CCG, CCG 
and TCG). (c) The coefficient of correlation between RNA methylation and trinucleotide 
sequences was found to be consistent between samples from the same species (Pearson 
correlation = 0.96 for human and 0.92 for mouse) and also between human and mouse 
cells (Pearson correlation = 0.72, 0.75, 0.45 and 0.48). 
 
Negative correlation in methylation level is observed between mRNA and the 
corresponding exonic region of DNA 
 
We next examined whether there exists any correlation between m5C methylated/non-
methylated (m5C methylation ratio) in transcriptome and the corresponding DNA exonic 
regions at each C-centred trinucleotide sites. Because DNA methylation occurs mainly at 
CG dinucleotides, as expected we observed no strong correlation at non-CG 
trinucleotides.  However, we observed significant negative correlation in methylation 
ratios between RNA and DNA at all four CG-containing trinucleotides. As a higher 
percentage of m5C in mRNA is detected, the corresponding DNA exonic CG dinucleotide 
was less likely to be methylated (Figure 7a).  Next, we grouped m5C methylated at all CG 
sites according to their methylation ratio (methylated and unmethylated) and 
investigated their distributions in mRNA and the corresponding exonic regions of DNA. 
Consistent with our previous finding, we observed significant negative correlation in 
both human and mouse cells. In particular, 5’UTR in mRNA showed high methylation 




Figure 7. The methylation ratio of corresponding m5C DNA and mRNA CpG islands 
shows negative correlation. (a) Negative correlation is observed between DNA and 
mRNA methylation ratio consistently under all four CG containing trinucleotide (ACG, 
TCG, CCG and GCG) in both human and mouse, i.e., if a specific CG dinucleotide in 
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DNA is methylated, the corresponding dinucleotide in mRNA is significantly less likely 
to be methylated.  “*” labeled the top the 4 nucleotide contexts under which strongest 
correlation between DNA and RNA methylation level exists. (b) Comparative 
distributions of m5C methylated CG sites in DNA and RNA show an enrichment of sites 
with high methylation ratio in mRNA 5’UTR as opposed to an enrichment of low 
methylation ratio sites in DNA 5’UTR. The pattern is consistent in both human MCF10A 
cell line and mouse embryo stem cells. 
 
Transcriptome m5C sites exhibit a clustering effect 
 
 
Figure 8. Strong clustering effect exists in DNA methylation under CpG context. Figure 
shows the correlation in methylation level between two cytosine sites of a certain 
distance. Strong correlation is observed between cytosine sites with a smaller distance.  
 
In DNA methylation, it has been shown that correlation of methylation rates between 
two CpG sites is related to the distance (see Figure 8), and the clustering effect can be as 
high as 0.7 for probes within 200bp [54]. To address whether the mRNA m5C 
methylation also exhibits clustering effect, we examined the proportion of m5C sites that 
are within 10bp distance of another m5C sites, and compared this proportion with that 
from 1000 times of random permutation. Our analysis revealed that m5C showed 
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obvious clustering effect in both mRNA and DNA (Figure 9a and Figure 9b). In ESC cell 
line, more than 76.7% of the mRNA methylation sites had at least one methylation site 
mapped within 10nt flanked region, compared with 7.7% of such event by random 
permutation of methylation states on insignificant methylation sites of the methylated 
genes.  In mouse ESC and Brain cells, more than 43.02% and 30.06% of mRNA m5C 
methylation sites existed within the m5C-p-m5C dimmers, compared with expected rate 
of 1.02% and 0.77% of such dimmers by the random permutation. 
 
To further elucidate the clustering effect, we calculated the correlation of methylation 
ratio between two cytosine sites with a specific distance. To our surprise, mRNA 
methylation exhibited a stronger clustering effect compared with DNA (Figure 9c). In 
addition, the correlation of methylation ratio was consistently stronger within 1-3nt 
distance as revealed of higher correlation of methylation ratio (0.76 in MCF10A and 
0.79in ESC). These results indicated that most CpC dimer are co-methylated, the 
correlation of methylation ratio can be as high as 0.58 in MCF10A and 0.47 in ESC for 
Cytosine sites with a distance of 4-10nt. Though the overall clustering effect of DNA 
methylation was not as strong as mRNA methylation, when only CpG dinucleotide was 
considered, DNA methylation exhibited a stronger clustering effect than mRNA 











Figure 9. RNA m5C modification exhibits clustering effect. (a) Bar graph shows the 
proportion of clustered m5C sites within 10nt flanked regions. To evaluate the statistical 
significance, we generated 1000 permutated results as a comparison with the bars 
indicating a 99% confidence interval. Using these criteria, m5C methylation showed a 
strong clustering effect consistently on different RNA families and on different regions of 
mRNA in human and mouse. Around 50% of the m5C sites were clustered with each 
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other within a 10bp region. (b) DNA methylation also exhibited a clustering effect. 
However, the pattern is not that strong when all nucleotide contexts are considered (c) 
Line graph showing correlation between RNA/DNA m5C methylation and distance 
between cytosine sites.  RNA m5C methylation showed strong correlation with Cytosine 
sites that are immediately close to each other. The clustering effect of DNA methylation 
is strong when only CpG context is considered (Figure 8).	
 
Transcriptome m5C is strongly enriched in mitochondrial transcripts 
 
To further establish a physiological relevance of m5C distribution, we examined the 
methylation level of RNAs encoded in different chromosomes. Surprisingly, m5C 
modification was strongly enriched in RNAs transcribed specifically from mitochondrial 
DNA in normal and breast cancer cells as well as in mouse ESC and brain as revealed by 
enrichment odds ratio of 818.42949, 634.72723, 1028.52065 and 67.28553, respectively. 
In contrast, the enrichment odds ratios of RNA methylation for transcripts from other 
chromosomes were found to be roughly the same (Figure 10a). The RNA transcripts of 
all the major genes located on mitochondrial chromosome were significantly methylated 
(Figure 10b). Previously, it was reported that methyltransferase NSUN5 can regulate 
mitochondrial gene expression [55], and we speculate that RNA m5C may play a more 
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vital regulatory role in mitochondria related biological processes. 
 
Figure 10. m5C is enriched on mRNAs transcribed from mitochondrial DNA. (a) Bar 
graph depicting m5C mRNA methylation sites on different chromosomes. RNAs 
transcribed from mitochondrial DNA (M) showed drastically increased frequency of m5C 
sites (enrichment odds ratio of 818.42949, 634.72723, 1028.52065 and 67.28553). (b) 
Bar graph showing the number of methylated cytosine reads stacked with unmodified 
cytosine reads generated from 6 major classes of mitochondria genes. The RNA 





Dys-regulation of RNA methylome in breast cancer 
Comparison of normal (MCF10A) and breast cancer (MDA-BM-468) m5C 
epitranscriptome identified 162 significant differential methylation sites (DMSs) located 
on 47 annotated genes at significance level of 0.05. Among the 47 differentially 
methylated genes, 35 shows hypo-methylation and 12 shows hyper-methylation in 
cancer cells compared with normal control cell line. The majority differential 
methylation sites are hypo-methylation (Figure 11a), and the m5C hypo-methylations are 
mostly located in CDS and 3’UTR region of mRNA but not in 5’UTR region (Figure 11b). 
We then investigated whether different m5C mRNA methylation levels in normal and 
breast cancer cells have any functional correlation. We performed functional gene set 
enrichment analysis on genes containing DMS using DAVID [113] web server and found 
that many of the 47 differentially methylated genes are related to important biological 
functions of cancer, e.g., regulation of apoptosis and programmed cell death with RTN4, 
NME2, CASP14, HSPB1, RPL11 and RPS3 differentially methylated. 
 
Interestingly, like the difference between breast cancer cell line MDA-MB-468 and 
normal epicelial cell line MCF10A, mechanistic similar mouse stem cells [56] also exhibit 
dominant hypo-methylation in m5C epitranscriptome when compared with mouse brain 
cells with 2513 genes hypo-methylated and 767 genes hyper-methylated (Figure 11c). 
Also similar to previous case, the hypo-methylations are mostly located in CDS and 
3’UTR regions of mRNA, but not in 5’UTR region (Figure 11d). Using DAVID, we found 
that hyper-methylated genes in ESC cells are mostly enriched with regulation of cell 
cycle (FZR1, E2F5, BOP1, TRRAP, CDK4, JUNB, etc), cell death (SIVA1, MCL1, YPEL3, ARF6, 
UBQLN1, SHF, CIAPIN1, APLP1, GPX1, CASP3, etc.) and mRNA metabolic process (SCAF1, 
FIP1L1, STRAP, RBM15B, CWC15, XAB2, YBX1, AUH, SF3B2, APLP1, HNRNPL, tec.); the 
hypo-methylated genes are enriched with functions related to ATP synthesis (ATP6V1F, 
ATP6V1C1, ATP6V0C, ATP6V1A, ATP6V0E, ATP6V1E1, ATP5C1, etc.), and mitochondrial 
ribosome (MRPL15, MRPL27, MRPL16, MRPL36, MRPL39, MRPL34, DAP3, etc.). These 
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results may suggest that the m5C methylations are selectively methylate on transcripts 
having biological functions related to the cell line conditions. 
 
 
Figure 11. Differential m5C mRNA methylation in different tissues. (a) Pie-diagram 
showing hypo- and hyper-methylation in MDA468 when compared to MCF10A. A total 
47 differential methylated genes were identified between breast cancer (MDA-MB-468) 
and normal control cell line (MCF10A) with primary hypo-methylation under cancer 
condition. (b) Bar graph showing odds ratio of hyper-methylation sites with respect to all 
differentially methylated sites on different regions of mRNA. Hyper-methylated sites 
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were strongly enriched in 5’UTRs. (c) Pie-diagram showing hyper-methylation in mouse 
embryo stem cells when compared to whole brain cells. (d) Bar graph showing odds ratio 
of hyper-methylation sites with respect to all differentially methylated sites on different 
regions of mRNA in the mouse experiment. Hyper-methylated sites were strongly 
enriched in 5’UTRs. 
 
Positive correlation between m5C mRNA methylation and expression changes 
In our data, as the gene expression is also estimated from RNA bisulfite sequencing data, 
a direct comparison of expression and m5C methylation changes may be problematic 
due to dependent noise. To eliminate the interference of dependent noise between 
expression and methylation data, the samples are further divided for different purposes. 
Specifically, the 3 biological replicates are divided into 2 groups, with the 1 sample used 
for estimation of expression changes and the other 2 samples for estimation of 
methylation changes. The expression changes and methylation changes are then 
compared. This procedure was repeated for 3 times using different grouping 
combinations.  
 
Figure 12. Positive correlations are observed between expression and mRNA m5C 
methylation fold change. To eliminate the interference of dependent noise between 
expression and methylation data, the samples are further divided for different purposes, 
and the test was repeated for 3 times using different ways of sample grouping. A strong, 
consistent and significant positive correlation is observed (0.274, 0.303 and 0.254) 
between log2 expression fold change and log2 methylation fold change when comparing 
mouse embryo stem cells with brain cells, suggesting that increased methylation level is 
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likely to be associated with increased expression level, but the underlying mechanism is 
not yet clear.  
 
A consistent and significantly positive correlation is observed (0.274, 0.303 and 0.254) 
between log2 expression fold change and log2 methylation fold change when comparing 
mouse embryo stem cells with brain cells (Figure 12), suggesting that increased 
methylation level is likely to be associated with increased expression level. Although the 
specific molecular mechanism is not yet clear, the observed positive correlation between 
RNA m5C and RNA expression confirmed our previous observed anti-correlation 
between DNA and RNA m5C methylation (see Figure 7) from a different perspective.   
  
To explain the positive correlation between expression and transcriptome m5C 
methylation, we compared the methylation status of all the genes and their half-life, 
where half-life of mouse genes were obtained from a previous study [57]. The mRNAs 
are classified into two groups based on whether they have at least one m5C site or not. 
To exclude the confounding factor (effective size in methylation site calling), a 
generalized linear model of binomial family was fitted to half-life with both expression 
and methylation information. Our result suggests that, there exists a significant positive 
correlation (pvalue = 2.23e-12) between mRNA half-life and its m5C methylation status in 
mouse embryo stem cells and the positive association is also confirmed on mouse whole 
brain dataset (pvalue = 0.0374). To further exclude the impact of mRNA expression in 
calling methylation status, we also extracted the genes whose log2 expression levels fall 
between 7 and 11, and then fit their mRNA half-life with a local regression. As shown in 
Figure 13, compared with the genes of a similar expression level but without an m5C 
site, the half-life of the mRNAs that carry m5C sites is clearly longer and the pattern is 
consistent in both mouse brain and ESC. This observation may contradict to the global 
hypo-methylation pattern demonstrated in the comparison between MDA468 and 
MCF10A, since most of the gene expressions in cancer cells will be upregulated. 
However, different from the global hypo-methylation, the m5C on 5’UTR are hyper-
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methylated in MDA468, which will suggest the contribution of RNA stability in cancer 




Figure 13. RNA m5C status is positively correlated with RNA half-life. In the above 
figure, each red dot represents a gene that carries m5C sites, and each blue dot represents 
a gene that does not carry an m5C sites.  When comparing the methylated and 
unmethylated genes of similar expression, the genes that carry an m5C site have longer 
RNA half-life than those do not carry m5C sites. (a) Positive correlation between RNA 
methylation status and RNA half-life is observed in mouse brain (pvalue = 0.0374, 
generalized linear model of binomial family). (b) Positive correlation between RNA 
methylation status and RNA half-life is observed in mouse embryo stem cells (pvalue = 
2.23e-12, generalized linear model of binomial family). 
Dys-regulation of RNA methylome after Simian Retrovirus Infection  
Simian retrovirus (SRV) infection of Jurkat T lymphocytes (Jurkat cells) was confirmed by 
syncytia formation, of which the membrane of the neighboring cells fused to one 
another. At 10 days postinfection, the formation of syncytium was observed among the 
Jurkat cells incubated with SRV (Figure 14a). The syncytium of Jurkat cells contains 
multiple nuclei and its size is dramatically larger than a single cell. SRV long terminal 
repeats (LTRs), which are reverse-transcribed from the RNA genome during the infection, 
contain critical sequences necessary for the integration, synthesis, and expression of 
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viral DNA [1]. Therefore, the extent of SRV infection was assayed by monitoring SRV-LTR 
expression in Jurkat cells through quantitative realtime PCR. As shown in Figure 14b, the 
copy number of SRV-LTR was gradually increased from 2 days to 10 days postinfection 
and then tended to be stable afterwards. Taken together, these results indicated that 
SRV was able to infect Jurkat cells and the infection reached maximum level after 10 
days postinfection.  
In order to investigate whether SRV could replicate in Jurkat cells, the SRV virions 
released in the culture medium were determined by measuring viral genome copy 
number through quantitative realtime PCR. As shown in Figure 14c, the copy number of 
SRV genome was gradually increased during 2 days to 14 days postinfection, suggesting 
that SRV was able to replicate in Jurkat cells. 
We then measured the RNA methylome with bisulfite sequencing. A total of 2475 m5C 
sites located on 517 genes are reported as differentially methylated 10 days post 
infection of SRV with QNB p value < 0.05. Among them, 389 sites located on 158 genes 
are hypo-methylated; while 2086 sites from 382 genes are hyper-methylated. A gene 
ontology analysis using the DAVID website suggests that the differentially methylated 
genes are related to virus infection, specifically, hyper-methylated genes are enriched 
with DNA replication (pvalue = 6.07E-5), mitotic nuclear division (pvalue = 4.37E-4), DNA 
replication initiation (pvalue = 3.48E-3), autophagosome assembly (pvalue = 8.54E-3), 
strand displacement (pvalue = 1.42E-2), double-strand break repair via homologous 
recombination (pvalue = 3.42E-3), etc.; while hypo-methylated genes are enriched with 
the following biological processes, including, negative regulation of epidermal growth 
factor receptor signaling pathway (pvalue = 3.24E-3), DNA damage checkpoint (pvalue = 
2.54E-2), cell migration (pvalue = 1.42E-2), etc (see Figure 14). Similar to before, a 
positive correlation (0.07) is observed between RNA methylation level and expression 
level; however, as there are 23 genes that carry hyper and hypo-methylated sites 








Figure 14. Dysregulation of RNA methylome after SRV infection of Jurkat Cell. (a) 
At 10 days postinfection, uninfected or SRV-infected Jurkat cells were stained with SRV 
antibodies (green). Nuclei were visualized by Hoechst staining (blue). Arrows indicate 
the syncytium of infected cells. Scale bar: 50µM. (b) The relative level of SRV-LTR in 
infected Jurkat cells was measured every two days by realtime PCR. GAPDH was used 
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as the internal control. The relative level of SRV-LTR at each time point was normalized 
to the data at 2 dpi; mean ± SD, n=3. (c) The absolute copy number of SRV genome in 
culture medium was measured every two days by realtime PCR. SRV-LTR and SRV 
genome were not detected in all uninfected cells and culture medium respectively; mean 
± SD, n=3. (d) The differentially methylated genes are enriched with the following 
functions, including DNA replication (pvalue = 6.07E-5), mitotic nuclear division (pvalue 
= 4.37E-4), DNA replication initiation (pvalue = 3.48E-3), autophagosome assembly 
(pvalue = 8.54E-3), strand displacement (pvalue = 1.42E-2), double-strand break repair 
via homologous recombination (pvalue = 3.42E-3), etc.; while hypo-methylated genes are 
enriched with the following biological processes, including, negative regulation of 
epidermal growth factor receptor signaling pathway (pvalue = 3.24E-3), DNA damage 
checkpoint (pvalue = 2.54E-2), cell migration (pvalue = 1.42E-2), etc. (see Figure 14). 
(e) A weak but positive correlation (Pearson correlation = 0.07) is observed between 
RNA methylation level and expression level, which is consistent our previous result; 
however, as there are 23 genes that carry hyper and hypo-methylated sites 
simultaneously, which implies that RNA m5C carries more complicated biomolecular 
functions. 
 
1.5 Discussion and Conclusion 
The distribution of m5C methylation in mRNA has been mysterious with inconsistent 
evidence reported from previous studies [35, 37]. Here, we profiled the human and 
mouse m5C epitranscriptome using RNA BS-Seq data in human MCF10A, human 
MDA468, mouse ESC, and mouse whole brain cells. To eliminate the data sample bias, 
we employed a rigorous quality control procedure by filtering false positive m5C sites 
due to secondary structure and performed a comprehensive comparative analysis on 
cross-species conserved locus, cross-sample comparison of topological transcriptome 
distributions of m5C, and differential m5C analysis. Our analysis clearly shows that m5C is 
enriched at 5’UTR in human and mouse cells, confirming the discovery of a few 
independent studies [35, 36, 47]. Additionally, an unambiguous correlated methylation 
pattern is observed on 5’UTRs, but not on CDS and 3’UTR, in different mouse and human 
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cell lines/tissues, suggesting a more complex aggregation pattern of m5C that may be 
further characterized. Together, these observations strongly imply the functional 
relevance of m5C RNA methylation and 5’UTR of mRNA. It is important to note that, 
although we failed to observe a correlated m5C methylation pattern on CDS and 3’UTR 
regions of mRNA, it is still possible that such pattern may emerge on strictly matched cell 
lines/tissues.  
 
When comparing the DNA and RNA methylome in matched cell lines in human and 
mouse, a negative correlation in the methylation level is observed on matched locus on 
DNA and RNA, which is quite surprising given that the methyltransferase of DNA and 
RNA may share strong sequence homology [53]. And this anti-correlation pattern is 
consistent at all four CG containing trinucleotides contexts, and ruled out the possibility 
of sample contamination or off-target effect, which should both lead to false positive 
correlation in data. It is possible that there exist a underlying biomolecular mechanism 
that function on matched locus of DNA and RNA in parallel to ensure their orchestrated 
methylation status.     
 
Similar to DNA methylation, a clustering effect of m5C on mRNA is also observed in both 
human and mouse. The local dependency, i.e., adjacent cytosine locus often exhibit 
similar methylation status, has been widely used in DNA methylation data analysis for 
more robust and accurate quantification of epigenetics status [58-60].  It is reasonable to 
expect that similar statistical approaches may be carried over into the field of single-
base resolution RNA methylation data to enhance the analysis of bisulfite RNA 
methylation sequencing data. It is worth to mention that, around 30%-43% of m5C 
residuals exist in pair in our results after filtering potential secondary structures that 
may lead to incomplete conversion and false positive m5C sites. The number may be 
over- or under-estimated because of the unfiltered secondary structure, which leads to 
an over-estimation of the clustering effect, and structured regions excluded from the 
analysis, which may affect the estimation in both directions. It is necessary to develop 
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more sensitive unbiased approach that can eliminate the impact of RNA structure to 
more accurately assess the distribution of transcriptome m5C modification. 
 
Intriguingly, we observed a strong enrichment of m5C methylation on mitochondrial 
transcripts with more than 50 folds of enrichment. Previously, it was reported that 
methyltransferase NSUN5 can regulate mitochondrial gene expression [55], and we 
speculate that RNA m5C methylation may play a more vital regulatory role in 
mitochondria related biological processes.  
 
Additionally, in order to have a glimpse of the dynamics of m5C on mRNA, differential 
RNA methylation analysis was performed between breast cancer cell line MDA-MB-468 
and the control cell line MCF10A, a total of 47genes are reported to be differentially 
methylated, including RTN4, NME2, CASP14, HSPB1, RPL11 and RPS3, which are related 
to apoptosis and programmed cell death. Although we showed previously that m5C on 
mRNA are more likely to be linked to 5’UTR function, it is observed that the differential 
methylation sites between breast cancer cell line and normal control cell lines are mostly 
located on CDS and 3’UTR. These observations together implied a profound role of m5C 
methylation on different regions of mRNA and in cancer pathology. 
 
Interestingly, an overall positive correlation between RNA m5C methylation and RNA 
expression level is observed in our mouse and human datasets, which added to the 
growing importance of mRNA m5C methylation in regulating gene expression. Although 
the specific molecular mechanism is not yet clear, the observed positive correlation 
between RNA m5C and RNA expression echoes our previous observed anti-correlation 
between DNA and RNA m5C methylation from a different perspective, because it has 
been well established that DNA methylation is anti-correlated with RNA expression. 
However, as is known that the most abundant RNA modification m6A methylation may 
enhance or reduce the stability of RNA molecule through interaction with different m6A 
readers [14, 61] or regulates RN-protein interaction [62], it is reasonable to assume that 
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RNA m5C may have versatile functionalities, and may get dominated by distinct 
mechanism under a specific condition.  
 
In summary, our study presented an in-depth topological characterization of the m5C 
RNA methylome in human and mouse. There are interesting patterns depicted and 
quantified, which call for further studies and novel biomolecular mechanisms for 
explanation.  
 
1.6 Availability of data and materials 
The data analysed in this study is obtained from public resources, including DNA BS-Seq 
data from MCF10A (GEO GSM659628), transcriptome m5C methylation data from  
MCF10A, MDA468 (GSE84230), mouse embryo stem cell (ESC), and mouse whole brain 
(GEO GSE83432), and mouse ESC DNA methylation data (GSM1873374) [7, 36, 42].  
 
The rBS2ndStructure R package for filtering artifacts in RNA bisulfite sequencing data is 
publically available at Github (https://github.com/ZW-xjtlu/rBS2ndStructure) with 
precomputed RNA secondary structures of mouse and human genome mm10 and hg19 














TREW: a database for the epitranscriptome targets of RNA 
modification readers, writers and erasers in human, mouse and 
fly 
 
2.1 Outline   
Motivation: Epitranscriptome has emerged to be an important layer for gene expression 
regulation. With the advancements in high-throughput sequencing technology, the 
transcriptome-wide distribution of various RNA modifications such as m6A, m5C, m1A, 
and ψ (pseudo-uridination) become increasingly available; however, till this day, the 
gene regulatory circuit at the epitranscriptome layer is still not comprehensively 
mapped or effectively integrated.  
Result: Post-transcriptional RNA modifications are directly recognized, deposited or 
removed by cognate factors termed readers, writers and erasers. By integrating the 
information from 36 independent high-throughput sequencing experiments, an online 
database TREW was built to host 171,551 epitranscriptome targets of the RNA 
modification readers, writers and erasers predicted un- der different biological contexts 
in human, mouse and fly. To facilitate the query, search and browse of this database, 
the target information has been integrated into a genome browser and annotated by 
their association to genes, consensus motifs and microRNA binding sites, etc.  





2.2. Introduction  
Our knowledge of the epitranscriptome has been greatly expanded with the 
advancements in high-throughput sequencing techniques such as m6A-seq, miCLIP, 
Bisulfite-seq, Aza-IP, Ψ-seq and m1A-seq [63, 64]. Epitranscriptome has emerged as an 
important layer for gene expression regulation, where a number of important biological 
functions are regulated through reversible RNA modifications [65]. With the efforts of 
bioinformatics community, the transcriptome-wide distribution of various RNA 
modifications is publically available from RMBase and MeTDB [66, 67]; however, till this 
day, the gene regulatory network at the epitranscriptome layer is still not 
comprehensively mapped or effectively integrated.  
Post-transcriptional RNA modifications are directly regulated by protein factors 
including the readers, writers and erasers [68]. For RNA N6-methyl-adenosine (m6A) 
modification, METTL3, WTAP, METTL14 and KIAA1429 have been identified as the 
components of RNA m6A methyltransferase complex (writer) [69, 70], while FTO and 
ALKBH5 are discovered as m6A demethylase (eraser) [71, 72].  
 
Figure. 1. Dynamic regulation of m6A methylation. M6A modifications on messenger 
RNAs are dynamically regulated by 3 groups of proteins: Writers, Erasers, and Readers. 
Writers are methyltransferase that could convert adenosine into m6A. Erasers are 
demethylase that could convert m6A back into adenosine. Readers could bind to m6A 
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modified mRNAs with m6A binding domains, and they will regulate the m6A modified 
mRNAs by recruiting downstream effectors.  
 
YTH family proteins YTHDF1, YTHDF2, and YTHDF3 can bind with the m6A modified 
nucleotides (reader) and regulate translation [73]. Besides, such protein regulators are 
also identified for other types of RNA modifications, e.g., m1A can be erased by ALKBH3 
[64], while Ψ is deposited by PSUS1.  
It is important to note that, the direct regulators of the epitranscriptome do not target 
aimlessly but exhibit substrate specificity. E.g., the m6A demethylase FTO and ALKBH5 
are able to discriminate substrates with very similar nucleotide sequences [74]; while 
after the perturbation of WTAP, METTL14 and KIAA1429, the m6A methyl-transferase 
complex exhibited altered substrate preference [70]. However, despite there exists a 
number of published experiments studying the context-specific regulatory effects of 
RNA modification readers, erasers and writers, such information has not been 
integrated into existing databases of RNA modifications such as RMBase [67], Met-DB 
[66] and MODOMICS (Machnicka, et al., 2012) [75] [75]. Hence, we developed TREW, 
which denotes the database for the epitranscriptome targets of RNA modification 
readers, erasers and writers. TREW includes the targets information of RNA modification 
readers, erasers and writers for multiple modification types in human, mouse and fly 
collected from different biological contexts, presenting an important collection of the 
regulatory circuit at the epitranscriptome layer for current researchers in RNA 
epigenetics.  
 
2.3. TREW database 
A total of 171,551 RNA modifications sites that preferentially targeted by a specific 
protein regulator (RNA modification reader, writer or eraser) in human, mouse and fly 
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are collected from 36 sets of high- throughput sequencing experiments in 16 studies. 
The records are predicted from different techniques (ParCLIP, Aza-IP, m6A-seq, Bisulfite- 
seq, Ψ-seq and m1A-seq) with corresponding data processing pipelines and cover 5 
major RNA modification types (m6A, m5C, m1A, hmrC and ψ). The collected target sites 
are further annotated with transcript regions (5’UTR, CDS, 3’UTR, stop codon, 
transcription starting sites, miRNA target site) and RNA types (tRNA, mRNA, lncRNA, 
sncRNA). The annotated data are then imported into an SQL-lite database (see 
supplementary materials for more information), based on which the TREW web server is 
created under Shiny web framework and embedded with JBrowse genome browser [76].  
Three query modes are supported in TREW database for different purposes, including:  
• General Query: This mode allows the query based on target gene  or the 
regulator. A summary and the detailed records from each species are 
returned (see Figure. 2), and they are linked to a genome browser for 
visualization purpose.   
• Orthologous Query: The query under this mode is similar to species-specific 
query, except that the records from different species are merged together, 
which inexplicitly assumes that the regulator of RNA modification is also 
conserved across different species, just like the modification site itself [77, 
78]. This query mode may be particularly useful for integrated analysis of 
closely related species, such as human and mouse.   
• Browsers: this mode allows the users to directly browse and search the 




Figure. 2. Query result of CDK6. A summary is returned with records from different 
species. CDK6 is predicted from MeRIP-seq and ParCLIP to be preferentially methylated 
by METTL3 in 2 different human cell lines. It is also targeted by m6A reader YTHDF1 
in 2 ParCLIP samples performed in human Hela cell line. Detailed information will be 
provided when the relevant summary record is selected. 
 
2.4 Raw Data Collection 
 
The transcriptome wide m6A methylation is mostly detected by technique of m6A-
Seq[79]. In m6A-Seq, purified RNAs are fragmented into ~100 nt fragments. Then, the 
fragments undergo Immunoprecipitation (IP) with anti-m6A antibodies. After RNA-seq 
sequencing, the reads are aligned to the genome; The IP group and input control group 
(the fragments without IP) are compared to infer the genomic locations containing m6A 
methylation. 
 
TREW database collects the binding sites of m6A methyltransferases (METTL3, WTAP, 
METTL14 and KIAA1429), demethylases (FTO and ALKBH5) and readers (YTH family 
proteins). To determine the target sites, ParCLIP-seq data were retrieved directly from 
original publications, where the raw data were processed with Trim Galore and FASTX-
Toolkit (v0.0.13) for quality control, and then aligned to human hg19 or mouse mm10 
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reference genome respectively with Tophat2[80]. Also, differential m6A analysis was 
performed with exomePeak and QNB packages[50] under the default setting on MeRIP-
seq data of m6A methylase or demethylase perturbation. The significant differential 
m6A peaks after perturbation were determined to the target peaks. Please refer to the 
Supplementary File 1 for the detailed documentation of the data sources, data 
processing pipelines, and app interface instructions for TREW database. 
 
2.5 Analysis of Data Consistency  
 
17 m6A-Seq datasets from TREW were selected for the evaluation of target consistency, 
all of them have experimental design to study the m6A changes after the knock down or 
over expression of m6A regulators. The raw reads are trimmed and aligned with 
trim_galoure, fastx_trimmer, tophat2 [80], and hisat2[81]. The aligned reads are 
counted by 101 nt bins centered by m6A annotations of single based resolution. 
 
The annotations used for m6A-Seq quantifications consist of m6A sites from RMBase2 
[67], TSS Adenine of Ref-Seq, and 6 miCLIP datasets (A technique that can detect m6A in 
single based resolution). The count results on mouse (mm10) are lifted over to human 
(hg19). Roughly 30% of the annotations are conserved between human and mouse after 
Liftover. The following analysis is performed on 146310 conserved methylation sites 
between human and mouse. 
 
The methylation and differential methylation (DM) analysis is conducted in DeSeq2 [51]. 
For samples with biological replicates, the cut-off was set at adjusted p values < 0.05, 
and for samples without biological replicates, the cut-off was set at p values < 0.05. If 
the reported methylation sites have number < 10000 for a given dataset, the extra sites 
are reported by order of p values until the number reached 10000. For differential 
methylation, the minimum number reported was set at 5000. For purpose of control, 
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the reversed methylated sites and reversed differentially methylated sites are reported 




Quality control  
The quality of the data is examined by 2 methods: 1. the distribution of exon length of 
the methylated sites, and it is expected that the highly methylated sites are enriched on 
long exons; 2. the distribution of the methylated sites on transcript coordinate, and it is 
expected that the m6A sites are enriched around stop codon. For all the datasets, the 
significant methylated sites are enriched in long exons and stop codons compared with 
the reversed methylated sites (See Supplementary File 2).  
 
The same metrics are applied to examine the quality of the differential methylation. All 
the writers show selectivity toward long exons and stop codons. This confirms with the 
previous study [69]. However, the erasers show different patterns of genomic features 
compared with writers. Most of the eraser targeted sites cannot demonstrate clear 
enrichment on long exons and stop codons compared with the reversed DM sites.  
Although the annotation sites used for quantification are high confidence m6A sites, the 
enrichment of erasers targets on long exons and stop codons are generally weak.  Hence, 
the selectivity of erasers may not be governed by the genomic features that are 
important to predict high methylation levels. 
 
- Visualizing Similarities  
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The similarities between the datasets are evaluated by a 2 by 2 contingency 
table. Odds ratio (OR) is used to measure the similarities on the contingency 
table, and the square root of unsymmetrical distance is used to measure the 
dissimilarities. 
  
The log2 OR is visualized by heat map (Figure 3) with maximum values truncated at 5. 
the hierarchical clustering based on the entries of the matrix shows that the writers and 
erasers can form 2 clusters. We further verify the clustering results with MDS (multiple 
dimensional scaling) (Figure 4); the distances between the dots on the MDS plot are 
approximately equal to the unsymmetrical distances. However, we cannot observe the 
clustering effect within the same writer regulator. The results may suggest that the 
writer proteins are part of a big methyl-transferase protein complex, and they might 
function as a single unit. The eraser proteins also form a single cluster, and it indicates 
that Fto and alkbh5 show similar target specificities on m6A. 
Data Set 1 




Figure 3. Heat Map of Odds Ratio Between Samples. The entries in the matrix are 
Log2 Odds Ratio associations of the significantly expected DM sites and the significantly 
inverse DM sites between different perturbed MeRIP-Seq data sets. The association 
values are truncated at 5. The hierarchical clustering results based on the OR matrix are 
labelled at the margin. The dendrogram indicates that the data sets could be divided into 2 
clusters, where the clustering partition can be clearly explained by the distinction of 
Writers and Eraser regulators. In addition, the writer and eraser proteins show higher 




Figure 4. MDS Plot of Asymmetrical Distances Between Samples.  MDS is conducted 
on the square root of asymmetrical distances calculated from the same contingency table 
of the OR association values. The plot based on the 2 scaling coordinates indicate that the 
expected differential methylation profiles are indeed demonstrated consistency within the 
writer and eraser groups. 
  
To further evaluate the statistical significance of the clustering, we fit a linear regression 
model on log2 OR between different samples. The model selection is conducted with 
the R package BAS. Based on the Bonferroni adjusted p values of Wald test. We 
identified 3 significant predictors with adjusted p < 0.05 to explain the OR variabilities; 
the significant predictors are writers (padj = 2.44e-23), erasers (padj = 5.06e-05), and 
cell lines (padj = 0.0001). The complete linear model results and model diagnosis are 




Figure 5. Linear Regression Model on log2 OR values. A linear regression model is 
fitted on log2 OR matrix using predictors of the 7 dummy variables. The variables are 
indicator of weather the 2 data sets belong to the same regulator group, cell lines, study, 
or species.  The coefficient estimates are significantly positive for variables of Writer, 
Eraser, and Cell lines, which indicates the statistical significant contribution to the target 
consistency. Also, the diagnosis plot indicates the assumption of linear regression model 
is satisfied. 
  
To explain the details of the specificities, we construct a logistic regression model with 
25 predictors of transcriptomic features (Table 1). The features are used to classify sites 
into consistently targeted sites and consistently not targeted sites for either writers or 
erasers. The consistently targeted sites are defined by the sites that are targeted by at 
least 2 datasets; the consistently un-targeted sites are defined by the sites that are 
reversely targeted in at least 2 datasets. The contradictory sites that mapped to both 
groups are removed from our analysis. 
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 Predictor names Definition 
1 Protein coding Sites mapped to exons of coding genes. 
2 CDS/5’UTR/3’UTR Sites mapped to coding sequence/5’UTR/3’UTR. 
3 Long exon Sites mapped to exons longer than 400bp. 
4 Last exon Sites mapped to the last exon in a transcript. 
5 Introns Sites mapped to introns. 
6 Relative positioning The relative position of sites on spliced transcript. 
7 TSS 100bp downstream of the TSS 
8 Stop codon 400bp centered by stop codon. 
9 Start codon 200bp centered by start codon. 
10 DRACH/BCA Sites on DRACH/BCA consensus motif. 
11 Struc Sterm/loop Loop/sterm of thermal stable RNA structures 
12 PC score1/200 PhasCons Score in bins of 1nt and 200 nt. 
13 HK genes Sites on housekeeping genes. 




overlapping with PARCLIP datasets in TREW of HNRNPC, YTHDF2, 
YTHDF1, and YTHDC1 
Table 1. The Feature Names and Their Definitions. Genomic related features are 
constructed to predict the regulator specificities of consistent writer and eraser targets. 
The genomic features are created based on the m6A topological significance 






The final model is selected by BAS. A robust coefficient prior and a beta binomial 
(1, 1) model prior are selected. After 20000 iterations of MCMC sampling, the 
final model is determined by the best predictive model (BPC) method. 
  
The bar plot in Figure 6 indicates the logit (log odds) estimates and the z statistics of 
wald test in the BPMs. The more positive or negative of the logit, the more enlargement 
or shrinkage it can made toward the probabilities of the sites being specifically targeted. 




Figure 6. Logistic Regression Models using Genomic Features. The plots above 
demonstrate the coefficients or logits estimates of the logistic regression models using 
genomic features. The response variables used are consistent targets of writers and 
erasers. Both of the model prdictors are selected using Bayesian model selection methods 
under the best predictive model criterion. The resulting coefficient estimates are all 
statistical significant under Wald tests after Bonferroni correction. The targets of writers 
and erasers show substantial differences on their profile of associations with genomic 
features. 
 53 
   
From the logistic model, we can infer that the selectivities of the writers and erasers are 
explained by different transcript features. Specifically, writer prefer long exons and stop 
codon, which help us to explain most of the deviances in the data. Erasers prefer looped 
RNA 2ndary structure, 5’UTR, and BCA motif. Additionally, both of the writer and eraser 
are highly associated with YTHDF2 binding site. This result suggests that both of the 
target selectivities are enriched on true m6A modification sites rather than potential 
false-positive sites. 
  
We confirmed that the writers and erasers have different specificities, and the 
specificities are evolutionary conserved. We also observed that the eraser specificities 
are highly structural driven, and the writer specificities are exon length and stop codon 
driven. The structural dependency of erasers was also suggested by a wet experiment 
study [74], and our results confirmed the picture of the regulator specificities from a 
computational approach. We present an alternative but more comprehensive approach 
to infer the specific structural, topological, and functional factors that drive the 
specificities of eraser and writer proteins.  
 
2.6 High accurate m6A site prediction with hand crafted genomic features. 
 
Most existing RNA modification site prediction algorithms use exclusively sequence-
based features; however, the sequence-derived features alone may not fully capture the 
attributes of RNA modification topology. Hence, we generated 45 additional genomic 
features that may contribute to the prediction. Genomic Features 1-13 are dummy 
variable features indicating whether the adenosine sites fall within the transcript regions 
that satisfy certain topological properties. All of the features in this category are 
generated by GenomicFeatures R/Bioconductor package using the transcript annotations 
hg19 TxDb package. To remove the ambiguity caused by transcript isoforms, only the 
primary (longest) transcripts of each gene were kept for the extraction of the transcript 
sub-regions. Genomic Features 14-16 are real valued features defining the relative 
 54 
position of the transcript regions. Specifically, it is defined by distance from the adenine 
to the 5’ end divided by the total width of the region; for the adenosine sites not belong 
to the region, the position features are set 0. Genomic features 17 to 19 represent the 
length of the transcript region containing the modification site. The values are also set to 
0 for sites that not belong to the region.  Features 20-22 captures the nucleotide 
distance of adenine sites toward the 5’end/3’end of the splicing junctions. Additionally, 
the distance to the nearest neighboring m6A sites in the training data is generated to 
measure the clustering effect of the m6A RNA modification. Features 23-26 represent 
the evolutionary conservation score of the adenosine sites and its flanking regions; 2 
metrics of nucleotide conservation, Phast-Cons score [83] and the fitness consequence 
scores [84], are used to measure the conservation level of the underlying nucleotide 
sequence. Features 27 and 28 represent the RNA secondary structures around the 
adenine site, the RNA secondary structures are predicted on the exon regions using 
RNAfold in Vienna RNA package [85]. At last, features 29-35 are the properties of the 
genes or transcripts containing the m6A sites, such as the miRNA target genes and the 
housekeeping genes. The annotation of microRNA target sites are from miRanda [86] 
and TargetScan [87].  
 
Details about the genomic features used in the prediction model.  
Together, 69 features were crafted to predict the m6A sites on both the full transcript 
regions and exons, and 35 of them were selected in the final prediction model using the 
method of recursive feature elimination. The 35 features used in the final model are: 
Table 7. Genomic Features Selected in the Whistle classifier  
 
ID Name Description Note 
1 UTR5 5' UTR 
Dummy variables 
indicating whether the 
site is overlapped to 
the topological region 
on the major RNA 
transcript. 
2 UTR3 3' UTR 
3 Stop_codons stop codons flanked by 100bp 
4 Start_codons start codons flanked by 100bp 
5 TSS downstream 100bp of TSS 
6 TSS_A downstream 100bp of TSS on A 
7 exon_stop exons containing stop codons 
8 alternative_exon alternative exons 
9 constitutive_exon constitutive exons 
10 internal_exon Internal exons 
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11 long_exon long exons (exon length >= 400bp) 
12 last_exon_400bp 5’ 400bp of the last exons [88] 
13 last_exon_sc400 5’ 400bp of the last exons containing stop codons [88] 
14 pos_UTR5 relative position on 5'UTR Relative position on 
the region 15 pos_UTR3 relative position on 3'UTR 16 pos_exons relative position on exon 
17 length_UTR5 5'UTR length The region length in 
bp. 18 length_UTR3 3'UTR length 19 length_gene_ex mature transcript length 
20 dist_sj_5_p2000 distance to the 5' splicing junction Nucleotide distances 
toward the splicing 
junctions or the 
nearest neighboring 
sites. 
21 dist_sj_3_p2000 distance to the 3' splicing junction 
22 dist_nearest_p200 distance to the closest neighbor truncated at 2000bp 
23 PC_1bp phastCons scores of the nucleotide [83] 
Scores related to 
evolutionary 
conservation 
24 PC_101bp average phastCons scores within the flanking 50bp region [83] 
25 FC_1bp fitCons scores of the nucleotide [84] 
26 FC_101bp average fitCons scores within the flanking 50bp region [84] 
27 struc_hybridize Predicted RNA hybridized region [89] RNA secondary 
structures 28 struc_loop Predicted RNA loop region [89] 
29 sncRNA sncRNA 
Attributes of the genes 
or transcripts 
30 lncRNA lncRNA 
31 HK_genes housekeeping genes [90] 
32 miR_targeted_genes miRNA targeted genes [91] 
33 HNRNPC_eCLIP eCLIP data of HNRNPC RNA binding sites [92]  RNA annotations 
related to m6A biology. 34 Verified_miRtargets miRNA targeted sites verified by experiment[93] 
35 TargetScan Predicted miRNA targeted sites by TargetScan[94] 
 
 
Machine learning approach used for m6A site prediction 
SVM is one of the most widely used machine learning algorithms in computational 
biology, which has been previously used for mammalian microRNA target prediction 
[95], protein kinase-specific phosphorylation sites prediction [96] and mammalian m6A 
modification sites prediction [97, 98]. In this project, we used an R language interface of 
LIBSVM [99] to construct the SVM-based m6A site predictors. The radial basis function 
was chosen as the kernel function, and other parameters were set at the default.  
  
Performance evaluation of m6A site prediction 
For the SVM classifier, a 5-fold cross-validation is employed on the training datasets for 
model selection purpose, and the final performance of the predictor is measured on the 
independent testing dataset. The ROC (receiver operating characteristic) curve 
 56 
(sensitivity against 1-specificity) is used to measure the prediction performance under 
different decision thresholds, and the area under ROC (AUC) was calculated as the main 
performance evaluation metrics.  
 
When evaluating the accuracy of m6A site information stored in existing 
epitranscriptome m6A site databases MeT-DB Version 2 and RMBase Version 2, the 
reliability is determined by the number of experiments that support the existence of a 
specific m6A site, based on which the AUC can be calculated. In addition, the sensitivity 
(  ), specificity ( ) and Matthews correlation coefficient ( ) were calculated to 
measure the performance of predictor: 
   (3) 
   (4) 
   (5) 
where, , ,  and  represent true positive, true negative, false positive, and 
false negative, respectively.  
 
The performance of the proposed m6A predictors are then evaluated using independent 
datasets and compared with competing approaches. As shown in Table 8. By combining 
additional genome-derived features, the performances of our approach are substantially 
higher on all the tested conditions than MethyRNA and SRAMP, which relies on only 
information extracted from sequences. The WHISTLE achieved AUCs of 0.960 and 0.895 
under the full transcript and mature mRNA modes, respectively, representing a major 
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Table 8. Performance of m6A Site Prediction 
Model Method 
Performance on Independent Dataset (AUC) 
Average 
AUC 





WHISTLE  0.973 0.947 0.962 0.954 0.976 0.947 0.960 
MethyRNA* 0.844 0.837 0.781 0.884 0.824 0.807 0.830 
SRAMP 0.871 0.859 0.791 0.900* 0.861 0.794 0.835 
Mature 
mRNA 
WHISTLE 0.923 0.922 0.911 0.904 0.857 0.856 0.895 
MethyRNA* 0.796 0.786 0.724 0.825 0.759 0.742 0.772 
SRAMP 0.833 0.820 0.738 0.884* 0.824 0.754 0.794 
 
We thus performed a whole transcriptome prediction of m6A RNA methylation sites in 
human to generate a map of human m6A epitranscriptome using our proposed WHISTLE 
approach. Our predicted map is of substantial higher accuracy (average AUC of 0.960 
and 0.895) compared with existing epitranscriptome databases MeT-DB (average AUC of 
0.833 and 0.782) and RMBase (average AUC of 0.822 and 0.775) when evaluated on 















gcepc: R package to conduct GC content bias aware exonic 
peak calling and quantification in meRIP-Seq 
 
3.1 Outline   
MeRIP-Seq represents the most popular type of high through-put assay which are 
widely used in RNA epitranscriptomic research. In MeRIP-Seq, the locations of RNA 
modifications under a given cellular condition are often inferred from the statistical 
enrichment of the reads coverage in IP (immune-precipitated) samples over the input 
control samples. However, similar to RNA-Seq, as a type of 2nd generation sequencing, 
we observed that substantial technical variation is arised from quantification in MeRIP-
Seq experiments due to the GC content bias induced during the PCR amplification 
process of the sequenced fragments. In addition, the GC content biases are usually 
correlated with the laboratory conditions, leading to systematic batch related errors in 
peak calling and modification level quantifications. gcepc is a novel software package 
which employs advanced statistical models to account for the GC content bias and 
biological variations. Compared with exomePeak, gcepc could significantly improve the 
accuracy of peak calling and modification level quantification while reducing the effect 
of batch variation under different laboratory conditions. Moreover, gcepc supports 
various meaningful functionality such as differential analysis and modification 
quantification.  





3.2. Introduction  
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Messenger RNA modifications represents a layer of post-transcriptional regulation that 
plays a crucial role in deciphering the precise mechanism for mRNA turn over, 
translation, and subcellular localization[100]. With the rapid development of 
epitranscriptomics, large amounts of high throughput assays are generated by different 
laboratories to measure the RNA modification profiles under different cellular 
conditions. Among the published datasets, MeRIP-Seq [101] (Methylated RNA 
immunoprecipitation sequencing) is the most commonly used HTP technique to assess 
the location and density of RNA modifications on messenger RNA transcripts.  
As a RNA-Seq based HTP experiment, MeRIP-Seq extracts the ploy-A RNA transcripts 
from cell. The RNA transcripts are firstly fragmented into small RNA segments of 50 – 
100 bp in lengths, and the RNA segments are separated into 2 groups: one is the IP 
group which is immune-precipitated by modification specific antibody; the other is the 
input group which is the control smaple to account for the background transcript 
expression level. The fragmented RNAs containing the RNA modification will be enriched 
by the anti-modification antibodies and therefore being over represented in the IP 
samples. The enrichment on reads abundance of IP over input samples will reveal the 
location and intensities of RNA modification under a given transcript region. 
The modification sites are often identified by peak calling algorithms from the MeRIP-
seq data. The most popular peak calling algorithms in MeRIP-seq are Mayer’s 
method[102], MACS[103], and exomePeak[79]. The Mayer’s method employs a fisher’s 
exact test to examine the association between IP&input labels with the particular 
genomic regions. The reads counts in Mayer’s method are derived from the sliding 
windows generated on exonic regions of the RNA transcripts. MACS is a peak calling 
software developed for CHIP-Seq data. It applies a Poisson statistical model with a 
flexible background parameter estimator to identify the targetd protein binding sites on 
the whole genome. exomePeak is a R package which conducts MeRIP-Seq peak calling 
on exons, the corresponding inference method for RNA modification targeted sites is 
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the exact Poisson test (c-test) on the differences between 2 Poisson means of the IP and 
input samples. 
All the previous methods mentioned above neglect the feature specific GC content 
biases which are prominent in RNA-Seq related assays. In addition, the classical methods 
are unable to incorporate the over-dispersed variation which is common in mesarsures 
of gene expression levels among biological replicates. To address these important 
problems, gcepc employs the generalized linear model (GLM) of negative binomial (NB) 
family with a feature specific offset which takes the GC content bias into consideration. 
Under the default settings, GLM of NB used in gcepc inherents the models developed by 
DESeq2[51] which applies a regularized estimation method on the over-dispersion 
parameter using counts of all the features under a given condition. 
 
3.2. The gcepc Peak Calling Pipeline 
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Figure1. The peak calling pipe-line of gcepc, the input for gcepc are the BAM files, genomic sequences, 
and transcript annotations. During Peak Calling, gcepc will first estimate the GC content offsets on user 
defined features, which could be the background bins that are searched by a GMM on quantities of log2 
IP/input fold changes. The peak calling is then conducted on bins with GC content correction using GLM 
of NB. A second round of quantification will be conducted on merged bins to estimate the (differential) 
modification statistics by DESeq2.  
As is shown in Figure1, gcepc takes the aligned reads of IP and input samples in BAM 
format as inputs. Given the transcript annotation files in either GFF or TxDb formats 
provided by the user, a sliding window will be generated on exon regions with the 
widths equalling to the size of antibody binding lengths (default set to be 25bps). The 
5’POS of the reads are counted on bins flanked by the length 
of	(𝑓𝑟𝑎𝑔𝑚𝑒𝑛𝑡	𝑙𝑒𝑛𝑔𝑡ℎ	– 	𝑏𝑖𝑛𝑑𝑖𝑛𝑔	𝑙𝑒𝑛𝑔𝑡ℎ) and the step size of the sliding window is set 













glm with design: ~ IP
Differential methylation















After collecting the read count statistic on the bins, the sequencing depth will be 
estimated on the bins using the robust sequencing depth estimator introduced in 
DESeq[104] followed by the estimation of the GC content linear effect which is 
estimated on each sample for bins with the average reads count > 50 across biological 
replicates. The filter for bins with low variance will be applied on IP and input separately. 
For each sample, the bin specific offsets of GC content bias are the centred fitted values 
estimated by a median regression between GC content and log reads count, this 
approach is firstly introduced in the CQN[105] method. 
In order to effectively estimate the technical effect of GC content without the 
confounding between the biological association of GC and modification signal, the scope 
for the GC linear effect estimation can be limited to the background bins (i.e. the bins 
without modification signals). The background region is by default identified using a 
Gaussian mixture model (GMM) on the log2 IP/input enrichment ratio across bins with 
average reads count > 50. Other methods for the background identification are also 
implemented in gcepc such as using the prior information of the m6A modification 
topology. 
 
The Statistical Model involved in gcepc peak calling. The reads count 𝐾3,5 in window 𝑖 and sample 𝑗 
conditioning on the IP treatment of sample 𝑗 is modelled by a negative binomial distribution with mean 𝜇3,5 
and over dispersion parameter 𝛼3,5. The regression equation of the conditional mean is modelled by a 
design with dummy variable of sample 𝑗 being the input sample. An additional offset variable 𝑡3,5is 
included in the regression equation. The offset parameter is defined by the last 2 lines of equations: the 
conditional specific GC content linear effect 𝑓3,5 is estimated using a median regression (QR with q = 0.5) 
on the logarithm of reads count for bins with average count > 50. Natural cubic splines with 5 knots are 
applied for the feature expansion. The final offset is the sum of the logarithm of the sequencing depth 
Ki, j | ρ( j) ~ NB(µi, j ,  α i, j )
log(µi, j ) = β0, i + β1, iΙ(ρ( j) = IP))+ ti, j
f̂i, j =QR(y = log(Ki, j );x = Xi )
ti, j ≡ exp[ f̂i, j (Xi )+ log(m̂ j )−
1
n





estimate and the centred GC content linear effect (for model identifiability). The peak calling is conducted 
using the 2-sided Wald test on the GLM coefficient 𝛽:,3. 
The modification status on bins are determined using a Wald test on the GLM of NB with 
the indicator variable of IP samples as the regression covariate. By default, the GLM 
used in gcepc is the GLM of NB implemented in DESeq2, which has a regularized 
estimation on the over-dispersion parameter. The offset of the GLM in peak calling is set 
to be the sum of the sequencing depth and the centered GC content linear effect 
estimates. 
After the inference of the significantly modified bins, the bins which have p values less 
than 1 × 10>? are regarded as the modification positive bins. The positive bins are 
merged into modification peaks, and only the peaks longer than 2 ×binding lengths are 
kept in the downstream analysis. The count statistics are re-quantified on the merged 
modification peaks, and the same GLMs in DESeq2 are fitted on peaks to report the final 
log2 IP/input fold changes as well as other peak statistics. The GLM offsets used in peak 
quantification are re-calculated using the GC content of the underlying sequence 
covered by the peak. 
3.3. Additional Functionalities Supported by Gcepc 
• Differential analysis 
Experimental design containing the differential analysis of MeRIP-Seq data is common 
among the published epitranscriptomic studies [69, 82]. Comparison between multiple 
conditions (sometimes has the perturbation of writers/erasers) are usually conducted in 
methods lacking model based rigoriousity. gcepc is the first package that supports the 
differential analysis of MeRIP-Seq data while adjusting the GC content bias. 
 
The differential analysis is conducted after a standard peak calling pipeline while 
interactive GLMs using the above regression equation are fitted on the modification 
peaks, the peaks in differential mode are called using the pooled samples of the 
log(µi, j ) = β0, i + β1, iΙ(ρ( j) = IP))+ β2, iΙ(ρ( j) = Treatment))+ β3, iΙ(ρ( j) = IP&Treatment))+ ti, j
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treatment and control condition. The coefficient estimates of the interactive terms 𝛽A,3  
are the log2 Fold Change estimate of the differential modification. A 2-sided Wald test is 
applied on the differential log2FC to identify the significantly differentially modified RNA 
modification targets. 
• Quantification on Single Based RNA Modification Annotation 
gcepc supports the modification quantification and differential modification analysis on 
single based modification annotation. The modification sites with single based 
resolution can provide a more accurate mapping of modification locations compared 
with the peaks which report the regions of RNA modification rather than the specific 
sites.  
Some of the datasets in epitranscriptomics have a single based resolution, such as the 
data generated by the m6A-CLIP-Seq or m6A-miCLIP-Seq techniques. Reads count on the 
single based modification sites could also provide a more accurate and consistent 
quantification on MeRIP-Seq experiments by eliminating of the technical variation 
introduced by the differences in the peak lengths.  
The 5’POS of the reads are count into the single based modification sites and are flanked 
by the width (𝑓𝑟𝑎𝑔𝑚𝑒𝑛𝑡	𝑙𝑒𝑛𝑔𝑡ℎ	– 	𝑏𝑖𝑛𝑑𝑖𝑛𝑔	𝑙𝑒𝑛𝑔𝑡ℎ/2).	The methods of quantification 
and differential analysis used are consistent with the standard pipeline. In other word, 
gcepc will treat the single based modification sites as modification peaks in the 
downstream analysis. 
 
3.4. The GC Conetent Biases Observed in MeRIP-Seq Experiments 
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Figure2. The observed differences in GC content - reads count linear relationships between different 
laboratories under the same cell line condition. The curve on the graph represents the smooth regression 
(Gaussian Kernel Method) estimates of the linear relationship between GC content and the reads count, the 
features used for reads count are the single based m6A sites collected from miCLIP/m6A-CLIP 
experiments. The IP samples are labelled as the dotted lines. We could observe that the IP sample has 
different linear relationships between different batches, while the GC content linear relationships are highly 
variable within the same experimental batch. 
To reduce the variation introduced by the inconsistent peak lengths, the reads 
abundance is quantified using the experimentally verified single based m6A sites which 
are the same set of sites of the positive training data in WHSTLE[106]. The linear 
relationships between reads abundance are different under different laboratory 
conditions for the same cell line condition of human liver cells (Figure 2). Such 
differences may be mainly attributed to the technical variation during the PCR 
amplification process of the RNA fragments under different laboratory conditions.  
 
The different in the GC content linear relationships will directly lead to the deviance of 
the statistical inferences during the peak calling process (Figure 3), which may 
potentially lead to the false positive peak calls under regions with extreme levels of GC 
contents. Additionally, GC content bias will lead to systematic error during the process of 
modification level quantification, hence it will lead to biased result in differential 




Figure3. The GC content biases observed in IP/input log2FC estimates and the inference of 
significant modified sites using DESeq2. The difference in GC content linear effects on the IP over input 
log2 Fold Change estimates is also observed, which suggests the DESeq2 model does not overcome the 
systematic biases introduced by the GC content. The inference over the significant modification also 
demonstrates the differences in the GC contents distributions among different directioanlities of the null 
hypothesis being rejected.  
 
 
Figure4. The GC content biases observed in differential log2FC estimates and the inference over 
significantly differentially modified sites with DESeq2. As the quantification and inference of IP/input 
fold changes, the interactive effect estimates are strongly affected by the GC content. This phenomenon is 
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demonstrated in 2 datasets generated by different laboratories that are both investigating the effect of FTO 
knockdown on m6A.  
 
3.5. Peak Calling Performance Evaluation  
 
Figure5. Performance of peak calling evaluated on 20 m6A-Seq datasets. Using the site predicted by 
WHISTLE as the ground truth data, the performance of peak calling is evaluated by the AUPRC metrics. 
The Y axis in figure 5a and 5b indicates the improvement of AUROC compared with random predictions 
(random shuffle of the positive predicted bins). Figure 5a indicates that the GC content correction (labelled 
as GC on x-axis) can lead to the improvement of AUROC on both the c-test and DESeq2 test peak calling 
methods. However, the effects of quantile normalization (labelled as qtnorm on x-axis) and background GC 
effect estimation (labelled as bg prior & bg GMM) are weak in peak calling performance context. Figure 5b 
further confirmed the improvement of peak calling performances using Deseq2 + GC content normalization 
compared with exomePeak. 
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To evaluate the performance of peak calling on MeRIP-Seq datasets, we generated a set 
of predicted modification sites using WHISTLE classifier on mature RNA. The predictions 
of WHISTLE classifier are made on the whole exon region of the hg19 genome. All the 
RRACH sites with posterior probability > 0.5 are labeled as positive sites while the rest 
them are labeled as the negatives.  
Using the default peak calling process of gcepc, exons are first divided into bins of 25bp 
in length. Different statistical tests are applied to infer the bins with significant 
modifications, and the p-value returned are filtered with different decision values to 
generate AUPRC (Area Under Precision-Recall Curve). When accounting for the overlap 
between the bins and m6A sites, each bin is resized into the width of 201bp fixed by 
their centre. In our case, Recall is defined as the proportion of positive m6A sites 
overlapped with positive bins. Precision is defined as the proportion of positive bins 
overlapped with positive m6A sites.  
After evaluating the prediction performance on 20 independent MeRIP-Seq experiment, 
the result showed that the methods implemented in gcepc have better prediction 
performances of m6A site prediction compared with the traditional model used in 
exomePeak (Figure 5). Moreover, the DESeq2 method does have superior performances 
on peak calling compared with exomePeak over 20 samples. Importantly, the inclusion of 
GC content correction offset does improve the peak calling performance globally over 
the 20 samples. However, the estimation of GC content correction offsets on background 
will on average not lead to further performance improvement. This outcome might 
indicate that the biological selectivity of m6A modification is not highly dependent on GC 
content. 
3.6. Reduction of the batch effect for m6A level quantification 
The benefits of normalizing over GC content linear effects on reads abundance are not 
only to reduce the within group technical variance, it could also reduece the groupwise 
variance by eliminating the major source of technical variance correlated with 
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experiment batches. This phenomenon is demonstrated by a clustering analysis on 32 
MeRIP-seq experiments from different laboratories (Figure 6). The modification levels of 
the 32 MeRIP-seq experiments are quantified using the log2( DE	FGHIJK:
3ILHJ	FGHIJK:
) approach 
and the method developed in gcepc. The clustering is conducted after the methylation 
levels are rescaled by samples. The log2FC estimated using gcepc demonstrates greater 
within cluster similarities, also the clustering partition on gcepc group is more consistent 




Figure6. Reduction of batch effect evaluated by the hierarchical clustering of samples. Compared with 
the traditional quantification method of log2 IP over input ratio. The dendrogram learned from the log2FC 
estimated by gcepc is the most consistent to the label of tissue information. Also, the within cluster 
distances for the latter is much smaller, which indicates the reduction of the within sample variations. 
The significance of GC content correction can also be demonstrated by the clustering 
analysis of modification sites. Before clustering, the entries are first rescaled by columns 
and then rescaled by rows. The clustering analysis is conducted on the top 10000 
modification sites having the highest variance. The clustering algorithm used is the K-











































































































































































































































































































































































































































































































































analysis using the 55 genomic features on each cluster separately. For the clustering 
result, the quantification derived by the common method results in the most 
explanatory features dominated by the GC content features, and the total deviances 
reduction for each model are significant smaller than the model fitted on the matrix 
quantified by gcepc. Clustering result for the second matrix is more biologically 
explainable. Almost all of the 4 clusters in the gcepc quantified analysis are associated 
with the RNA binding sites of the crucial m6A regulators. 
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Proposed model deviance reduction: 1729.335, 1082.614, 833.278, 1218.736 on 55, 55, 55, 55 df
Multinomial logistic model against background: log2((IP + 1)/(Input + 1))
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Figure7. Contribution of Genomic features in explaining the clustering results of modification sites. 
The modification levels quantified on single based modification are clustered by features (sites) with K = 4. 
The association between 54 genomic features and each cluster label is examined by a logistic regression 
model. The bar plot above indicates the logit (log odds) estimate for each genomic feature, the bars labelled 
by red colour are the significant association by the FDR adjusted 2 sided Wald test, and the colour of the 
bars indicate the direction of association. We could observe the clustering analysis using gcepc 
quantification yields much meaningful clusters compared with the analysis conducted on the quantities of 
log2((IP+1)/(input +1)). 
In conclusion, the peak calling pipeline developed by gcepc could substantially improve 
the peak calling and quantification accuracy on MeRIP-Seq data. The improvement made 
is mostly due to the modeling over the biological variation and the GC content biases. In 
the future works, a more statistical rigorous method could be developed to unbiasedly 
estimate the technical GC content linear effect on IP samples, such as the one developed 
by gcapc[107] on CHIP-Seq data. Additionally, the estimation error of methylation level 
can be thoroughly studied with the different estimators (such as MLE and MAP of GLM) 
defined by DESeq2, a more rigorous bound could be used to decide the statistical 
reliability of the modification quantification on MeRIP-Seq data. 
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Proposed model deviance reduction: 2175.059, 1029.817, 1556.421, 1628.901 on 55, 55, 55, 55 df
Multinomial logistic model against background: gcepc
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3.8 Materials and Data Availabilitie 
 
ID Sample Label SRA Study SRR RUN Publication




2 HepG2-HS SRR456544-SRR456545 
3 HepG2-HGF SRR456546-SRR456547 
4 HepG2-IFN SRR456548-SRR456549 





7 Hela-METTL14- SRR847362-SRR847365 
8 Hela-WTAP- SRR847366-SRR847369 






















18 HEK293T-2 SRR1182595-SRR1182596 
19 OKMSfibro-Dox SRR1182597-SRR1182598 
20 OKMSfibro SRR1182599-SRR1182600 
21 OKMSiPC SRR1182601-SRR1182602 
22 A549-WTAP- SRR1182603-SRR1182606, SRR1182625-
SRR1182626 
23 A549-METTL14- SRR1182607-SRR1182614, SRR1182635-
SRR1182636 
24 A549-METTL3- SRR1182615-SRR1182618, SRR1182629-
SRR1182630 
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28 AML-1 SRR3066066-SRR3066069 
29 gsc11 SRR4310464-SRR4310465, SRR4310468-
SRR4310469 
p08 [72] 
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